Clinical data | |
---|---|
Trade names | Nembutal |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682416 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth, intravenous, intramuscular, rectal |
Drug class | Barbiturate |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 70–90% (oral); 90% (rectal) |
Protein binding | 20–45% |
Metabolism | Liver |
Elimination half-life | 15–48 hours |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.895 |
Chemical and physical data | |
Formula | C11H18N2O3 |
Molar mass | 226.276 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Pentobarbital (US) or pentobarbitone (British and Australian) is a short-acting barbiturate typically used as a sedative, a preanesthetic, and to control convulsions in emergencies.[2] It can also be used for short-term treatment of insomnia but has been largely replaced by the benzodiazepine family of drugs.
In high doses, pentobarbital causes death by respiratory arrest. It is used for veterinary euthanasia and is used by some US states and the Federal government of the United States for executions of convicted criminals by lethal injection.[3] In some countries and states, it is also used for physician-assisted suicide.[4][5]
Pentobarbital was widely abused and sometimes known as "yellow jackets" due to the yellow capsule of the Nembutal brand. Pentobarbital in oral (pill) form is not commercially available.[3]
Pentobarbital was developed by Ernest H. Volwiler and Donalee L. Tabern at Abbott Laboratories in 1930.
:0
was invoked but never defined (see the help page).ABC
was invoked but never defined (see the help page).Stuff
was invoked but never defined (see the help page).© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search